AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Kuros Biosciences Ltd.

Earnings Release Feb 3, 2010

916_rns_2010-02-03_c682a001-8a2d-4229-ad17-b1bf95c8db09.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Corporate | 3 February 2010 07:00

Cytos Biotechnology announces full year 2009 financial results and major developments in 2009

Cytos Biotechnology AG / Final Results

03.02.2010

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.


Schlieren (Zurich), Switzerland, February 3, 2010 - Cytos Biotechnology Ltd
(SIX:CYTN) today presented its full year 2009 financial results and annual
major developments.

The complete press release can be downloaded on Cytos Biotechnology's
website under the following link:

http://www.cytos.com/userfiles/file/Cytos_Press_E_100203.pdf

Wolfgang A. Renner, PhD
Chief Executive Officer
Cytos Biotechnology Ltd
Phone: +41 44 733 47 03
Fax: +41 44 733 47 04
e-Mail: [email protected]
Website: www.cytos.com

03.02.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: Cytos Biotechnology AG
Wagistr. 25
8952 Schlieren
Schweiz
Phone: +41 44 733 4747
Fax: +41 44 733 4740
E-mail: [email protected]
Internet: www.cytos.com
ISIN: CH0011025217, CH0029060735
WKN: -
Listed: Freiverkehr in Berlin, München, Stuttgart; Open Market in
Frankfurt; Foreign Exchange(s) SWX

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.